The vacuum blood collection devices market is projected to attain US$ 2.6 billion in 2023. Throughout the forecast period, the vacuum blood collection devices industry is projected to assume a CAGR of 6.3% to attain US$ 4.79 billion by 2033.
The vacuum blood collection devices industry is projected to expand owing to the following:
Attributes | Details |
---|---|
Vacuum Blood Collection Devices Market Size (2023) | US$ 2.6 billion |
Vacuum Blood Collection Devices Market Size (2033) | US$ 4.79 billion |
Vacuum Blood Collection Devices Market CAGR (2023 to 2033) | 6.3% |
With the rise in blood tests performed to diagnose chronic diseases such as diabetes, human immunodeficiency virus (HIV), anemia, and cardiovascular diseases, the adoption of vacuum blood collection devices is forecast to reach US$ 4.79 billion by the end of 2033.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rising prevalence of cancer has encouraged people for early diagnosis tests. Patients are opting for non-invasive diagnostic tools with growing awareness regarding the benefits of non-invasive test procedures.
Liquid biopsy has emerged as a promising and versatile non-invasive cancer diagnostic tool. Liquid biopsy analysis consists of circulating tumor cells, circulating cell-free nucleic acids, or other diseased cells from organs. This technique is especially acquiring immense popularity among the geriatric population.
With a surge in stabilizing reagents and the easy availability of vacuum blood collection devices, non-invasive diagnostic procedures have become easily accessible. As vacuum blood collection devices allow post-collection preservation of circulating cell-free DNA (cfDNA), medical professionals are increasingly advising liquid biopsy for cancer patients.
The evolution of the vacuum blood collection tube market depends on the blood preservation requirements after sample collection, which increases the interest in performing non-invasive diagnostic procedures. Advancements such as these are expected to provide a promising opportunity for the vacuum blood collection devices market.
Key players are fixating on creating technologically advanced and innovative products by investing in research and development activities to gain a competitive advantage. Increasing investment in research by biotechnology companies is also expected to provide ample growth opportunities for the market players.
Improvement and streamlining of regulatory processes and growing funding for life science research in developing countries are expected to boost the product portfolio and development of vacuum blood collection devices.
As key players are focusing on collaborations and the acquisition of regional distributors and other manufacturers for global expansion, the market is expected to witness impressive growth opportunities over the coming years.
According to Future Market Insights (FMI), the demand for vacuum blood collection devices recorded a CAGR of around 4.2% between 2018 and 2022. Increasing health check-ups due to the rising prevalence of chronic diseases, ease in sample collection and processing, and new product launches are the chief drivers, boosting the sales of vacuum blood collection devices.
As blood is considered a gold standard for diagnosis of infectious diseases and various other medical conditions, sales of vacuum blood collection devices market, have been witnessing significant growth during the pandemic phase. Factors such as these are expected to positively influence the development of the global vacuum blood collection devices market.
Future Market Insights projects the market to register a healthy CAGR of 6.3% by the end of 2033.
In 2023, the United States is expected to materialize as one of the most lucrative markets, accounting for a market share of over 87.3 % across North America. The growing popularity of health checkups drives growth in the country due to the rise in lifestyle and chronic disorders.
With advancements in biotechnology and ease in sample collection and processing, growth exhibited by the vacuum blood collection devices market is expected to improve. The presence of numerous key players in the country is the other factor driving the growth of the market in this region.
Germany is projected to dominate the Europe vacuum blood collection devices market, holding over 18.9% of the market share in 2023. Advancements in the market size can be credited to factors like increasing medical applications, growing product launches, technological advancements in the biotechnological industry, and the growing prevalence of chronic diseases in the country.
Country | China |
---|---|
Forecast CAGR % (2023 to 2033) | 9.7% |
The vacuum blood collection devices market in China is poised to expand at 9.7% CAGR through 2033. Demand is anticipated to increase due to the increase in diagnosis and physical examinations.
Favorable government policies, new product launches, and a rise in government funding for life science research are projected to boost the market. Growing product penetration and health awareness are among the key factors driving market growth in China.
Country | India |
---|---|
Forecast CAGR % (2023 to 2033) | 8.2% |
The vacuum blood collection devices market in India is anticipated to capture a CAGR of 8.2% during the forecast period. With a market share of over 69.3% in 2023, India is expected to spearhead the growth of South Asia.
Key factors aiding growth are the rising prevalence of infectious and chronic diseases in the country, an outbreak of contagious diseases such as COVID-19, and a rising focus on improving overall healthcare infrastructure.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Segment | Serum Separation Tubes |
---|---|
Forecast CAGR % (2023 to 2033) | 6.7% |
In terms of product, the serum separation tubes are projected to hold the maximum share of 24.1%, expanding at 6.7% CAGR during the forecast period. As these serum separator tubes (SST) provide rapid separation of serum from cellular constituents of blood, medical professionals are extensively using them for the diagnosis of contagious diseases.
A plethora of benefits, such as easy transportation, minimal need for aliquoting serum, and reduction of analytical errors, are making serum separation tubes highly sought-after in the vacuum blood collection devices market.
In terms of material, plastic/PET material is projected to account for 84.5% of the market share in 2023. Demand in this segment is expected to continue increasing due to PET material’s resistance to breakage and high steam sterilization tolerance. Also, it can sustain cold storage temperatures without mechanical fatigue and deformation, which makes it ideal for vacuum blood collection devices.
Segment | Routine Chemistry |
---|---|
Forecast CAGR % (2023 to 2033) | 7.1% |
In terms of application, routine chemistry is projected to account for 34.2% of the market share in 2023. Routine chemistry is used to evaluate the body's electrolyte balance and the status of several body organs and empower individuals to make informed decisions about health. Also, this application segment is expected to record a CAGR of 7.1% during the forecast period.
In terms of end user, diagnostic laboratories are projected to account for 46.6% of the market share in 2023. Demand in the segment is anticipated to continue swelling owing to a heightened incidence rate of multiple diseases such as diabetes, hepatitis B, cancer, heart diseases, and HIV AIDS, whose diagnosis requires various blood tests to confirm the severity of the disease.
New product releases and approvals have emerged as key growth approaches employed by leading players in the vacuum blood collection devices market. Followed by this, the acquisition was the second most common strategy adopted by the industry players. For instance:
Attributes | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ million/billion for value and Units for Volume |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and the Middle East & Africa |
Key Countries Covered | The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, and South Africa |
Key Segments Covered | Product, Material, Application, End User, and Region |
Key Companies Profiled | Becton, Dickinson, & Company; Greiner Bio-One GmbH; Guangzhou Improve Medical Instruments Co., Ltd; AB Medical, Inc.; SARSTEDT AG & Co. KG; Cardinal Health; Poly Medicure Ltd.; FL Medical; InterVac Technology; Chengdu Rich Science Industry Co., Ltd.,; Zhejiang Gongdong Medical Technology Co. Ltd.; Aptaca Spa.; Hindustan Syringes & Medical Devices; DJO Global Inc.; BTL; Spectro Analytic Irradia AB; Photomedex; others |
Report Coverage | Market Forecast, brand share analysis, competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is projected to reach US$ 4.79 billion by 2033.
Serum separation tubes hold a significant share of 24.1% though 2033.
Key players focus on collaborations, acquisitions, and global expansion.
China and India are significant players, growing at CAGRs of 9.7% and 8.2%, respectively.
The market is projected to register a CAGR of 6.3% by 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Serum Separation Tubes
5.3.2. Serum Clot Activators/Serum Gel + Clot Activator
5.3.2.1. Silica
5.3.2.2. Thrombin
5.3.3. Plasma Analysis/Anti-coagulants
5.3.3.1. EDTA Tubes
5.3.3.2. Lithium Heparin
5.3.3.3. Sodium Heparin
5.3.4. Coagulation Analysis Tubes
5.3.5. Glucose Analysis Tubes
5.3.5.1. Sodium Fluoride
5.3.5.2. Potassium Fluoride
5.3.5.3. Fluoride Oxide
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2023 to 2033
6.3.1. PET/Plastic
6.3.2. Glass
6.4. Y-o-Y Growth Trend Analysis By Material, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Material, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Serology & Immunology
7.3.2. Routine Chemistry
7.3.3. Blood Typing
7.3.4. Molecular Genetics
7.3.5. Blood Sugar Assay
7.3.6. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Diagnostic Centers
8.3.2. Hospitals & Clinics
8.3.3. Research & Academic Institutes
8.3.4. Veterinary Hospitals & Clinics
8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA.
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Material
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Material
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product
11.2.3. By Material
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Material
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United Kingdom.
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Product
12.2.3. By Material
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Material
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Product
13.2.3. By Material
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Material
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Product
14.2.3. By Material
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Material
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Product
15.2.3. By Material
15.2.4. By Application
15.2.5. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Material
15.3.4. By Application
15.3.5. By End User
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Product
16.2.3. By Material
16.2.4. By Application
16.2.5. By End User
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Product
16.3.3. By Material
16.3.4. By Application
16.3.5. By End User
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA.
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Product
17.1.2.2. By Material
17.1.2.3. By Application
17.1.2.4. By End User
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Product
17.2.2.2. By Material
17.2.2.3. By Application
17.2.2.4. By End User
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Product
17.3.2.2. By Material
17.3.2.3. By Application
17.3.2.4. By End User
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Product
17.4.2.2. By Material
17.4.2.3. By Application
17.4.2.4. By End User
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Product
17.5.2.2. By Material
17.5.2.3. By Application
17.5.2.4. By End User
17.6. United Kingdom.
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Product
17.6.2.2. By Material
17.6.2.3. By Application
17.6.2.4. By End User
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Product
17.7.2.2. By Material
17.7.2.3. By Application
17.7.2.4. By End User
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Product
17.8.2.2. By Material
17.8.2.3. By Application
17.8.2.4. By End User
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Product
17.9.2.2. By Material
17.9.2.3. By Application
17.9.2.4. By End User
17.10. Poland
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Product
17.10.2.2. By Material
17.10.2.3. By Application
17.10.2.4. By End User
17.11. Russia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Product
17.11.2.2. By Material
17.11.2.3. By Application
17.11.2.4. By End User
17.12. Czech Republic
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Product
17.12.2.2. By Material
17.12.2.3. By Application
17.12.2.4. By End User
17.13. Romania
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Product
17.13.2.2. By Material
17.13.2.3. By Application
17.13.2.4. By End User
17.14. India
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Product
17.14.2.2. By Material
17.14.2.3. By Application
17.14.2.4. By End User
17.15. Bangladesh
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Product
17.15.2.2. By Material
17.15.2.3. By Application
17.15.2.4. By End User
17.16. Australia
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Product
17.16.2.2. By Material
17.16.2.3. By Application
17.16.2.4. By End User
17.17. New Zealand
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Product
17.17.2.2. By Material
17.17.2.3. By Application
17.17.2.4. By End User
17.18. China
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Product
17.18.2.2. By Material
17.18.2.3. By Application
17.18.2.4. By End User
17.19. Japan
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Product
17.19.2.2. By Material
17.19.2.3. By Application
17.19.2.4. By End User
17.20. South Korea
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Product
17.20.2.2. By Material
17.20.2.3. By Application
17.20.2.4. By End User
17.21. GCC Countries
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Product
17.21.2.2. By Material
17.21.2.3. By Application
17.21.2.4. By End User
17.22. South Africa
17.22.1. Pricing Analysis
17.22.2. Market Share Analysis, 2022
17.22.2.1. By Product
17.22.2.2. By Material
17.22.2.3. By Application
17.22.2.4. By End User
17.23. Israel
17.23.1. Pricing Analysis
17.23.2. Market Share Analysis, 2022
17.23.2.1. By Product
17.23.2.2. By Material
17.23.2.3. By Application
17.23.2.4. By End User
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Product
18.3.3. By Material
18.3.4. By Application
18.3.5. By End User
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Becton, Dickinson, & Company
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Greiner Bio-One GmbH
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. Guangzhou Improve Medical Instruments Co., Ltd
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. AB Medical, Inc.
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. SARSTEDT AG & Co. KG
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Cardinal Health
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. Poly Medicure Ltd.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. FL Medical
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. InterVac Technology
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Chengdu Rich Science Industry Co., Ltd.,
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. Zhejiang Gongdong Medical Technology Co. Ltd.
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. Aptaca Spa.
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Hindustan syringes & Medical Devices
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
19.1.14. DJO Global Inc.
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.14.5.2. Product Strategy
19.1.14.5.3. Channel Strategy
19.1.15. BTL
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
19.1.15.5.2. Product Strategy
19.1.15.5.3. Channel Strategy
19.1.16. Spectro Analytic Irradia AB
19.1.16.1. Overview
19.1.16.2. Product Portfolio
19.1.16.3. Profitability by Market Segments
19.1.16.4. Sales Footprint
19.1.16.5. Strategy Overview
19.1.16.5.1. Marketing Strategy
19.1.16.5.2. Product Strategy
19.1.16.5.3. Channel Strategy
19.1.17. Photomedex
19.1.17.1. Overview
19.1.17.2. Product Portfolio
19.1.17.3. Profitability by Market Segments
19.1.17.4. Sales Footprint
19.1.17.5. Strategy Overview
19.1.17.5.1. Marketing Strategy
19.1.17.5.2. Product Strategy
19.1.17.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports